高性價比母乳低聚糖 HMOs哪里找？----上海甄準(zhǔn)生物
母乳低聚糖HMOs是*的天然分子具有較高的營養(yǎng)和生物醫(yī)學(xué)應(yīng)用潛力。HMOs具有多種生物活性。他們作為受體類似物抑制病原體粘附在上皮表面和與免疫系統(tǒng)直接交互作用。HMOs也認(rèn)為在出生后大腦發(fā)育中發(fā)揮作用。
上海甄準(zhǔn)生物提供性價比高的母乳低聚糖HMOs，為您的科學(xué)研究提供強(qiáng)有力的支持！
產(chǎn)品信息：甄準(zhǔn)母乳低聚糖HMOs
| 貨號 | 英文品名 | 中文品名 | CAS NO. | 描述 | 規(guī)格 |
| 中性母乳低聚糖 | |||||
| EOT-GLY031-3 | 2’Fucosyllactose / 2-FL | 2’-巖藻糖基乳糖 | 41263-94-9 | Fucα1-2Galβ1-4Glc | 5mg |
| EOT-GLY031-3 | 2’Fucosyllactose / 2-FL | 2’-巖藻糖基乳糖 | 41263-94-9 | Fucα1-2Galβ1-4Glc | 25mg |
| EOT-GLY060 | 3 Fucosyllactose / 3-FL | 3-巖藻糖基乳糖 | 41312-47-4 | Galβ1-4(Fucα1-3)Glc | 5mg |
| EOT-GLY060 | 3 Fucosyllactose / 3-FL | 3-巖藻糖基乳糖 | 41312-47-4 | Galβ1-4(Fucα1-3)Glc | 25mg |
| EOT-GLY072 | Isglobotetraose / iGb4 / Cytolipin R | 細(xì)胞糖脂R | GalNAcβ1-3Galα1-3Galβ1-4Glc | 5mg | |
| EOT-GLY010 | Lacto-N-tetraose / LNT | 乳糖-N-四糖 | 14116-68-8 | Galβ1-3GlcNAcβ1-3Galβ1-4Glc | 5mg |
| EOT-GLY010 | Lacto-N-tetraose / LNT | 乳糖-N-四糖 | 14116-68-8 | Galβ1-3GlcNAcβ1-3Galβ1-4Glc | 25mg |
| EOT-GLY021 | Lacto-N-neotetraose / LNnT / neo-LNT | 乳糖-N-新四糖 | 13007-32-4 | Galβ1-4GlcNAcβ1-3Galβ1-4Glc | 5mg |
| EOT-GLY021 | Lacto-N-neotetraose / LNnT / neo-LNT | 乳糖-N-新四糖 | 13007-32-4 | Galβ1-4GlcNAcβ1-3Galβ1-4Glc | 25mg |
| EOT-GLY033-1 | Lacto-N-fucopentaose I / LNFP I | 乳糖-N-巖藻戊糖 Ｉ | 7578-25-8 | Fucα1-2Galβ1-3GlcNAcβ1-3Galβ1-4Glc | 5mg |
| EOT-GLY033-1 | Lacto-N-fucopentaose I / LNFP I | 乳糖-N-巖藻戊糖Ｉ | 7578-25-8 | Fucα1-2Galβ1-3GlcNAcβ1-3Galβ1-4Glc | 25mg |
| EOT-GLY055 | Lacto-N-difucohexaose II / LNDFH II | 乳糖-N-二巖藻己糖II | 62258-12-2 | Galβ1-3(Fucα1-4)GlcNAcβ1-3Galβ1-4(Fucα1-3)Glc | 5mg |
| EOT-GLY055 | Lacto-N-difucohexaose II / LNDFH II | 乳糖-N-二巖藻己糖II | 62258-12-2 | Galβ1-3(Fucα1-4)GlcNAcβ1-3Galβ1-4(Fucα1-3)Glc | 25mg |
| EOT-GLY022 | Para-Lacto-N-neohexaose / Para-LNnH | Para-乳糖-N-新己糖 | 64331-48-2 | Galβ1-4GlcNAcβ1-3Galβ1-4GlcNAcβ1-3Galβ1-4Glc C40H68N2O31 | 5mg |
| EOT-GLY022 | Para-Lacto-N-neohexaose / Para-LNnH | Para-乳糖-N-新己糖 | 64331-48-2 | Galβ1-4GlcNAcβ1-3Galβ1-4GlcNAcβ1-3Galβ1-4Glc C40H68N2O31 | 25mg |
| EOT-GLY023 | Lacto-N-neooctaose / LNnO | 乳糖-N-新八糖 | Galβ1-4GlcNAcβ1-3Galβ1-4GlcNAcβ1-3 | 5mg | |
| EOT-GLY023 | Lacto-N-neooctaose / LNnO | Galβ1-4GlcNAcβ1-3Galβ1-4GlcNAcβ1-3 | 25mg | ||
| EOT-GLY062 | Lacto-N-fucopentaose V / LNFP V | 乳糖-N-巖藻戊糖V | 60254-64-0 | Galβ1-3GlcNAcβ1-3Galβ1-4(Fucα1-3)Glc | 5mg |
| EOT-GLY062 | Lacto-N-fucopentaose V / LNFP V | 乳糖-N-巖藻戊糖V | 60254-64-0 | Galβ1-3GlcNAcβ1-3Galβ1-4(Fucα1-3)Glc | 25mg |
| EOT-GLY061 | Lacto-N-neofucopentaose / LNnFP-V / LNFP VI | 乳糖-N-新巖藻戊糖 VI | Galβ1-4GlcNAcβ1-3Galβ1-4(Fucα1-3)Glc | 5mg | |
| EOT-GLY061 | Lacto-N-neofucopentaose / LNnFP-V / LNFP VI | 乳糖-N-新巖藻戊糖 VI | Galβ1-4GlcNAcβ1-3Galβ1-4(Fucα1-3)Glc | 25mg | |
| 酸性母乳低聚糖 | |||||
| EOT-GLY063 | 3’Sialyl-3Fucosyllactose / F-SL | 3’唾液酸化-3巖藻糖基乳糖 | Neu5Acα2-3Galβ1-4(Fucα1-3)Glc | 5mg | |
| EOT-GLY063 | 3’Sialyl-3Fucosyllactose / F-SL | 3’唾液酸化-3巖藻糖基乳糖 | Neu5Acα2-3Galβ1-4(Fucα1-3)Glc | 25mg | |
| EOT-GLY081 | LS-Tetrasaccharide a / LSTa / Sialyl-lacto-N-tetraose a | LS-四糖 a | 64003-53-8 | Neu5Acα2-3Galβ1-3GlcNAcβ1-3Galβ1-4Glc | 5mg |
| EOT-GLY081 | LS-Tetrasaccharide a / LSTa / Sialyl-lacto-N-tetraose a | LS-四糖 a | 64003-53-8 | Neu5Acα2-3Galβ1-3GlcNAcβ1-3Galβ1-4Glc | 25mg |
| EOT-GLY090 | GM3 Ganglioside sugar / 3'Sialyllactose / 3'SL / N-Acetylneuraminoyllactose | *GM3 | Neu5Acα2-3Galβ1-4Glc | 100mg | |
| 小分子母乳低聚糖 | |||||
| EOT-GLY035-3 | Blood group A antigen tetraose type 5 / PI | 血型A抗原類型5四糖 | 59957-92-5 | GalNAcα1-3(Fucα1-2)Galβ1-4Glc | 5mg |
| EOT-GLY035-3 | Blood group A antigen tetraose type 5 / PI | 血型A抗原類型5四糖 | 59957-92-5 | GalNAcα1-3(Fucα1-2)Galβ1-4Glc | 25mg |
| EOT-GLY035-3 | Blood group A antigen tetraose type 5 / PI | 血型A抗原類型5四糖 | 59957-92-5 | GalNAcα1-3(Fucα1-2)Galβ1-4Glc | 100mg |
| EOT-GLY037-1 | Blood group A antigen hexaose type 1 / PII | 血型A抗原類型1四糖 | GalNAcα1-3(Fucα1-2)Galβ1-3GlcNAcβ1-3 | 5mg | |
| EOT-GLY037-1 | Blood group A antigen hexaose type 1 / PII | 血型A抗原類型1四糖 | GalNAcα1-3(Fucα1-2)Galβ1-3GlcNAcβ1-3 | 25mg | |
| 其他哺乳類動物母乳低聚糖： | |||||
| 貨號 | 英文品名 | 中文品名 | CAS No. | 描述 | |
| EOT-GLY010 | Lacto-N-tetraose / LNT | 乳糖-N-四糖 | 14116-68-8 | Galβ1-3GlcNAcβ1-3Galβ1-4Glc | 25mg |
| EOT-GLY031-3 | Blood group H antigen triaose type 5 / 2’Fucosyllactose / 2-FL | 2’-巖藻糖基乳糖 | , 41263-94-9 | Fucα1-2Galβ1-4Glc | 5mg |
| EOT-GLY031-3 | Blood group H antigen triaose type 5 / 2’Fucosyllactose / 2-FL | 2’-巖藻糖基乳糖 | 41263-94-9 | Fucα1-2Galβ1-4Glc | 25mg |
| EOT-GLY060 | 3 Fucosyllactose / 3-FL | 3-巖藻糖基乳糖 | 41312-47-4 | Galβ1-4(Fucα1-3)Glc | 5mg |
| EOT-GLY060 | 3 Fucosyllactose / 3-FL | 3-巖藻糖基乳糖 | 41312-47-4 | Galβ1-4(Fucα1-3)Glc | 25mg |
| EOT-GLY090 | GM3 Ganglioside sugar / 3'Sialyllactose / 3'SL / N-Acetylneuraminoyllactose | *GM3 | 35890-38-1 | Neu5Acα2-3Galβ1-4Glc | 100mg |
| EOT-GLY021 | Lacto-N-neotetraose / LNnT / neo-LNT | 乳糖-N-新四糖 | 13007-32-4 | Galβ1-4GlcNAcβ1-3Galβ1-4Glc | 5mg |
| EOT-GLY021 | Lacto-N-neotetraose / LNnT / neo-LNT | 乳糖-N-新四糖 | 13007-32-4 | Galβ1-4GlcNAcβ1-3Galβ1-4Glc | 25mg |
| EOT-GLY070 | Isoglobotriaose / iGb3 / 3'-Galactosyl-lactose / Linear B-6 trisaccharide | 3'-半乳糖基-乳糖 | 56038-36-9 | Galα1-3Galβ1-4Glc | 5mg |
| EOT-GLY070 | Isoglobotriaose / iGb3 / 3'-Galactosyl-lactose / Linear B-6 trisaccharide | 3'-半乳糖基-乳糖 | 56038-36-9 | Galα1-3Galβ1-4Glc | 25mg |
| EOT-GLY070 | Isoglobotriaose / iGb3 / 3'-Galactosyl-lactose / Linear B-6 trisaccharide | 3'-半乳糖基-乳糖 | 56038-36-9 | Galα1-3Galβ1-4Glc | 100mg |
| EOT-GLY049 | LewisX (LeX) triaose / SSEA-1 / CD15 | LewisX三糖 | 71208-06-5 | Galβ1-4(Fucα1-3)GlcNAc | 5mg |
興旺寶